Clinical trial
Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
NCT00149227 · Kyoto Prefectural University of Medicine, Other · Completed
Key facts
| NCT number | NCT00149227 |
|---|---|
| Title | Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) |
| Official title | Add-on Effects of Valsartan on Morbi- Mortality in High Risk Hypertension |
| Lead sponsor | Kyoto Prefectural University of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Ischemic Heart Disease, Congestive Heart Failure, Stroke |
| Intervention type | Drug |
| Interventions | Valsartan, Non-ARB |
| Enrollment | 3,031 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 12, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: